Vallourec S.A. (LON:0NR2)
15.84
+0.04 (0.28%)
At close: Dec 30, 2025
Vallourec Revenue
Vallourec had revenue of 911.00M EUR in the quarter ending September 30, 2025, with 1.90% growth. This brings the company's revenue in the last twelve months to 3.83B, down -9.75% year-over-year. In the year 2024, Vallourec had annual revenue of 4.03B, down -21.12%.
Revenue (ttm)
3.83B EUR
Revenue Growth
-9.75%
P/S Ratio
0.98
Revenue / Employee
306.55K EUR
Employees
12,497
Market Cap
3.26B GBP
Revenue Chart
* This company reports financials in EUR.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 4.03B | -1.08B | -21.12% |
| Dec 31, 2023 | 5.11B | 231.02M | 4.73% |
| Dec 31, 2022 | 4.88B | 1.44B | 41.87% |
| Dec 31, 2021 | 3.44B | 199.34M | 6.15% |
| Dec 31, 2020 | 3.24B | -930.65M | -22.30% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Shell | 200.18B |
| BP p.l.c. | 138.32B |
| Unilever | 51.24B |
| AstraZeneca | 43.24B |
| HSBC Holdings | 43.13B |
| Rio Tinto Group | 39.22B |
| GSK plc | 32.17B |
| Barclays | 26.02B |